Literature DB >> 21697760

Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells.

Jamunarani Veeraraghavan1, Mohan Natarajan, Pallavi Lagisetty, Vibhudutta Awasthi, Terence S Herman, Natarajan Aravindan.   

Abstract

OBJECTIVES: Nuclear factor κB (NF-κB) plays an intrinsic role in promoting growth, angiogenesis, and metastasis in pancreatic cancer (PC) and serves as a mechanism underlying therapeutic resistance. Accordingly, we investigated the efficacy of bioactive phytochemicals in inhibiting radiotherapy (RT)-induced NF-κB activity, signaling, and NF-κB-dependent regulation of cell death.
METHODS: Panc-1, BxPC-3, and MIA PaCa-2 cells exposed to 10 Gy (single high dose [SDR]) or 2 Gy/d for 5 days (fractionated radiation [FIR]) with or without curcumin (CUR), neem leaf extract (NLE), or black raspberry extract (RSE) were analyzed.
RESULTS: Radiotherapy profoundly induced NF-κB-DNA-binding activity with relatively robust activation after FIR. Curcumin, NLE, and RSE significantly inhibited both constitutive and RT-induced NF-κB. Furthermore, quantitative polymerase chain reaction profiling of 88 NF-κB pathway molecules demonstrated that CUR, NLE, and RSE comprehensively, yet differentially inhibited FIR/SDR-induced genes. Functionally, CUR, NLE, and RSE markedly conferred RT-inhibited cell viability/survival, robustly activated caspase-3/7 activity, and subsequent cell death. More importantly, NF-κB overexpression and silencing studies demonstrate that these compounds potentiate RT-induced cell death by targeting RT-induced NF-κB.
CONCLUSIONS: These data strongly imply that CUR, NLE, and RSE may serve as effective "deliverables" to potentiate RT in PC cure and further throw light that these phytochemicals-induced cell killing may involve selective regulation of RT-induced NF-κB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697760     DOI: 10.1097/MPA.0b013e31821f677d

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  24 in total

1.  Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.

Authors:  Tulasigeri M Totiger; Supriya Srinivasan; Venkatakrishna R Jala; Purushottam Lamichhane; Austin R Dosch; Alexander A Gaidarski; Chandrashekhar Joshi; Shobith Rangappa; Jason Castellanos; Praveen Kumar Vemula; Xi Chen; Deukwoo Kwon; Nilesh Kashikar; Michael VanSaun; Nipun B Merchant; Nagaraj S Nagathihalli
Journal:  Mol Cancer Ther       Date:  2018-11-07       Impact factor: 6.261

2.  Treponema denticola increases MMP-2 expression and activation in the periodontium via reversible DNA and histone modifications.

Authors:  Islam M Ateia; Pimchanok Sutthiboonyapan; Pachiyappan Kamarajan; Taocong Jin; Valentina Godovikova; Yvonne L Kapila; J Christopher Fenno
Journal:  Cell Microbiol       Date:  2018-01-08       Impact factor: 3.715

3.  Acquired tumor cell radiation resistance at the treatment site is mediated through radiation-orchestrated intercellular communication.

Authors:  Natarajan Aravindan; Sheeja Aravindan; Vijayabaskar Pandian; Faizan H Khan; Satish Kumar Ramraj; Praveen Natt; Mohan Natarajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

4.  Neem (Azadirachta indica): prehistory to contemporary medicinal uses to humankind.

Authors:  Venugopalan Santhosh Kumar; Visweswaran Navaratnam
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

Review 5.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

Review 6.  Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.

Authors:  Roxane Khoogar; Byung-Chang Kim; Jay Morris; Michael J Wargovich
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-18       Impact factor: 4.052

Review 7.  The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.

Authors:  Yiwei Li; Vay Liang W Go; Fazlul H Sarkar
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

Review 8.  Trials with 'epigenetic' drugs: an update.

Authors:  Angela Nebbioso; Vincenzo Carafa; Rosaria Benedetti; Lucia Altucci
Journal:  Mol Oncol       Date:  2012-10-06       Impact factor: 6.603

Review 9.  Relationship and interactions of curcumin with radiation therapy.

Authors:  Vivek Verma
Journal:  World J Clin Oncol       Date:  2016-06-10

Review 10.  Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer.

Authors:  Gabrielle Wishart; Priyanka Gupta; Andrew Nisbet; Eirini Velliou; Giuseppe Schettino
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.